Audax Private Equity (“Audax”), a leading alternative investment manager and capital partner for North American middle market companies, announces it has entered into a definitive agreement to sell CorEvitas, LLC (“CorEvitas”), a leading provider of real-world evidence for regulatory approved medical treatments and therapies, to Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”). Based in Waltham, MA, CorEvitas is a provider of real-world evidence, leveraging proprietary data to help pharmaceutical customers uncover clinical insights that lead to safer, more effective treatments and better patient care.
Read the full article: Audax Private Equity Announces Agreement to Sell CorEvitas to Thermo Fisher Scientific //
Source: https://www.businesswire.com/news/home/20230706054090/en/Audax-Private-Equity-Announces-Agreement-to-Sell-CorEvitas-to-Thermo-Fisher-Scientific